Molecular evolution of the neuropeptide S receptor

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Pitti, Thejkiran ^a   Manoj, Narayanan ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID RECEPTOR; CARDIOACCELERATORY PEPTIDE RECEPTOR; NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE S RECEPTOR; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; VASOPRESSIN RECEPTOR; AMINO ACID; G PROTEIN COUPLED RECEPTOR; LIGAND; NPSR1 PROTEIN, HUMAN; PEPTIDE;

ARTICLE; CEPHALOCHORDATA; CONTROLLED STUDY; GENE CLUSTER; GENE STRUCTURE; GENETIC VARIABILITY; HEMICHORDATA; METAZOON; MOLECULAR EVOLUTION; MOLECULAR PHYLOGENY; NONHUMAN; ORTHOLOGY; PARALOGY; PEPTIDE ANALYSIS; SEQUENCE ANALYSIS; VERTEBRATE; ALGORITHM; AMINO ACID SEQUENCE; ANIMAL; BIOLOGY; CHEMISTRY; GENETICS; HUMAN; INTRON; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYLOGENY; PHYSIOLOGY; PROBABILITY; PROTEIN BINDING; PROTEIN MOTIF; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE; STATISTICAL MODEL;

INVERTEBRATA; METAZOA; TETRAPODA; VERTEBRATA;

ALGORITHMS; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; AMINO ACIDS; ANIMALS; COMPUTATIONAL BIOLOGY; CONSERVED SEQUENCE; EVOLUTION, MOLECULAR; HUMANS; INTRONS; LIGANDS; LIKELIHOOD FUNCTIONS; MARKOV CHAINS; MOLECULAR SEQUENCE DATA; PEPTIDES; PHYLOGENY; PROTEIN BINDING; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, VASOPRESSIN; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY;

EID: 84859141754     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034046     Document Type: Article

References (85)

1. Laitinen T, Daly MJ, Rioux JD, Kauppi P, Laprise C, et al. (2001) A susceptibility locus for asthma-related traits on chromosome 7 revealed by genome-wide scan in a founder population. Nat Genet 28 (1): 87-91.
2. Laitinen T, Polvi A, Rydman P, Vendelin J, Pulkkinen V, et al. (2004) Characterization of a common susceptibility locus for asthma-related traits. Science 304: 300-304.
3. Xu YL, Reinscheid RK, Huitron-Resendiz S, Clark SD, Wang Z, et al. (2004) Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43: 487-497.
4. Gloriam DE, Schioth HB, Fredriksson R, (2005) Nine new human rhodopsin family G-protein coupled receptors: Identification, sequence characterization and evolutionary relationship. Biochim Biophys Acta 1722 (3): 235-246.
5. Reinscheid RK, Xu YL, Civelli O, (2005) Neuropeptide S: a new player in the modulation of arousal and anxiety. Mol Interv 5 (1): 42-46.
6. Xu YL, Gall CM, Jackson VR, Civelli O, Reinscheid RK, (2007) Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain. J Comp Neurol 500: 84-102.
7. Sato S, Shintani Y, Miyajima N, Yoshimura K, (2002) Novel G protein-coupled receptor protein and DNA thereof. World Patent Application, WO 02/31145 A1.
8. Gupte J, Cutler G, Chen JL, Tian H, (2004) Elucidation of signaling properties of vasopressin receptor-related receptor 1 by using the chimeric receptor approach. Proc Natl Acad Sci U S A 101: 1508-1513.
9. Peng YL, Han RW, Chang M, Zhang L, Zhang RS, et al. (2010) Central Neuropeptide S inhibits food intake in mice through activation of Neuropeptide S receptor. Peptides 31: 2259-2263.
10. Beck B, Fernette B, Stricker-Krongrad A, (2005) Peptide S is a novel potent inhibitor of voluntary and fast-induced food intake in rats. Biochem Biophys Res Commun 332: 859-865.
11. Pape HC, Jungling K, Seidenbecher T, Lesting J, Reinscheid RK, (2010) Neuropeptide S: a transmitter system in the brain regulating fear and anxiety. Neuropharmacology 58: 29-34.
12. Duangdao DM, Clark SD, Okamura N, Reinscheid RK, (2009) Behavioral phenotyping of neuropeptide S receptor knockout mice. Behav Brain Res 205: 1-9.
13. Han RW, Yin XQ, Chang M, Peng YL, Li W, et al. (2009) Neuropeptide S facilitates spatial memory and mitigates spatial memory impairment induced by N-methyl-D-aspartate receptor antagonist in mice. Neurosci Lett 455: 74-77.
14. Li W, Chang M, Peng YL, Gao YH, Zhang JN, et al. (2009) Neuropeptide S produces antinociceptive effects at the supraspinal level in mice. Regul Pept 156: 90-95.
15. Vendelin J, Pulkkinen V, Rehn M, Pirskanen A, Raisanen-Sokolowski A, et al. (2005) Characterization of GPRA, a novel G protein-coupled receptor related to asthma. Am J Respir Cell Mol Biol 33: 262-270.
16. Nepomuceno D, Sutton S, Yu J, Zhu J, Liu C, et al. (2010) Mutagenesis studies of neuropeptide S identify a suitable peptide tracer for neuropeptide S receptor binding studies and peptides selectively activating the I(107) variant of human neuropeptide S receptor. Eur J Pharmacol 635: 27-33.
17. Bernier V, Stocco R, Bogusky MJ, Joyce JG, Parachoniak C, et al. (2006) Structure-function relationships in the neuropeptide S receptor: molecular consequences of the asthma-associated mutation N107I. J Biol Chem 281: 24704-24712.
18. Melen E, Bruce S, Doekes G, Kabesch M, Laitinen T, et al. (2005) Haplotypes of G protein-coupled receptor 154 are associated with childhood allergy and asthma. Am J Respir Crit Care Med 171: 1089-1095.
19. Pulkkinen V, Haataja R, Hannelius U, Helve O, Pitkanen OM, et al. (2006) G protein-coupled receptor for asthma susceptibility associates with respiratory distress syndrome. Ann Med 38: 357-366.
20. D'Amato M, Bruce S, Bresso F, Zucchelli M, Ezer S, et al. (2007) Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease. Gastroenterology 133: 808-817.
21. Reinscheid RK, Xu YL, Okamura N, Zeng J, Chung S, et al. (2005) Pharmacological characterization of human and murine neuropeptide s receptor variants. J Pharmacol Exp Ther 315: 1338-1345.
22. Okamura N, Habay SA, Zeng J, Chamberlin AR, Reinscheid RK, (2008) Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor. J Pharmacol Exp Ther 325: 893-901.
23. Camarda V, Rizzi A, Ruzza C, Zucchini S, Marzola G, et al. (2009) In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide S. J Pharmacol Exp Ther 328: 549-555.
24. Ruzza C, Rizzi A, Trapella C, Pela' M, Camarda V, et al. (2010) Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. Peptides 31: 915-925.
25. Reinscheid RK, (2007) Phylogenetic appearance of neuropeptide S precursor proteins in tetrapods. Peptides 28: 830-837.
26. Elphick MR, (2010) NG peptides: a novel family of neurophysin-associated neuropeptides. Gene 458: 20-26.
27. Vroling B, Sanders M, Baakman C, Borrmann A, Verhoeven S, et al. (2011) GPCRDB: information system for G protein-coupled receptors. Nucleic Acids Res 39: D309-319.
28. Eddy SR, (1998) Profile hidden Markov models. Bioinformatics 14: 755-763.
29. Neron B, Menager H, Maufrais C, Joly N, Maupetit J, et al. (2009) Mobyle: a new full web bioinformatics framework. Bioinformatics 25: 3005-3011.
30. Li W, Godzik A, (2006) Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics 22: 1658-1659.
31. Krogh A, Larsson B, von Heijne G, Sonnhammer EL, (2001) Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 305: 567-580.
32. Katoh K, Kuma K, Toh H, Miyata T, (2005) MAFFT version 5: improvement in accuracy of multiple sequence alignment. Nucleic Acids Res 33: 511-518.
33. Drummond AJ, Ashton B, Buxton S, Cheung M, Cooper A, et al. (2010) Geneious v5.1, [http://www.geneious.com].
34. Gouet P, Courcelle E, Stuart DI, Metoz F, (1999) ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics 15: 305-308.
35. Tamura KPD, Peterson N, Stecher G, Nei M, Kumar S, (2011) MEGA5: Molecular Evolutionary Genetics Analysis using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods. Mol Biol Evol 28: 2731-2739.
36. Abascal F, Zardoya R, Posada D, (2005) ProtTest: selection of best-fit models of protein evolution. Bioinformatics 21: 2104-2105.
37. Ronquist F, Huelsenbeck JP, (2003) MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics 19: 1572-1574.
38. Guo AY, Zhu QH, Chen X, Luo JC, (2007) [GSDS: a gene structure display server]. Yi Chuan 29: 1023-1026.
39. Betts MJ, Guigo R, Agarwal P, Russell RB, (2001) Exon structure conservation despite low sequence similarity: a relic of dramatic events in evolution? EMBO J 20: 5354-5360.
40. Brendel V, Xing L, Zhu W, (2004) Gene structure prediction from consensus spliced alignment of multiple ESTs matching the same genomic locus. Bioinformatics 20 (7): 1157-1169.
41. Gu X, Vander Velden K, (2002) DIVERGE: phylogeny-based analysis for functional-structural divergence of a protein family. Bioinformatics 18: 500-501.
42. Gu X, (1999) Statistical methods for testing functional divergence after gene duplication. Mol Biol Evol 16: 1664-1674.
43. Roch GJ, Busby ER, Sherwood NM, (2011) Evolution of GnRH: diving deeper. Gen Comp Endocrinol 171: 1-16.
44. Hoyle CH, (1999) Neuropeptide families and their receptors: evolutionary perspectives. Brain Res 848: 1-25.
45. Aikins MJ, Schooley DA, Begum K, Detheux M, Beeman RW, et al. (2008) Vasopressin-like peptide and its receptor function in an indirect diuretic signaling pathway in the red flour beetle. Insect Biochem Mol Biol 38: 740-748.
46. Kawada T, Sekiguchi T, Itoh Y, Ogasawara M, Satake H, (2008) Characterization of a novel vasopressin/oxytocin superfamily peptide and its receptor from an ascidian, Ciona intestinalis. Peptides 29: 1672-1678.
47. Stafflinger E, Hansen KK, Hauser F, Schneider M, Cazzamali G, et al. (2008) Cloning and identification of an oxytocin/vasopressin-like receptor and its ligand from insects. Proc Natl Acad Sci U S A 105: 3262-3267.
48. Ukena K, Iwakoshi-Ukena E, Hikosaka A, (2008) Unique form and osmoregulatory function of a neurohypophysial hormone in a urochordate. Endocrinology 149: 5254-5261.
49. Hansen KK, Stafflinger E, Schneider M, Hauser F, Cazzamali G, et al. (2010) Discovery of a novel insect neuropeptide signaling system closely related to the insect adipokinetic hormone and corazonin hormonal systems. J Biol Chem 285: 10736-10747.
50. Park JI, Semyonov J, Chang CL, Hsu SY, (2005) Conservation of the heterodimeric glycoprotein hormone subunit family proteins and the LGR signaling system from nematodes to humans. Endocrine 26: 267-276.
51. Dreborg S, Sundstrom G, Larsson TA, Larhammar D, (2008) Evolution of vertebrate opioid receptors. Proc Natl Acad Sci U S A 105: 15487-15492.
52. Sundström G, Dreborg S, Larhammar D, (2010) Concomitant duplications of opioid peptide and receptor genes before the origin of jawed vertebrates. PLoS One 5: e10512.
53. Ballesteros JA, Weinstein H, (1995) Integrated methods for the construction of three dimensional models and computational probing of structure function relations in G protein-coupled receptors. Methods Neurosci 25: 366-428.
54. Warne T, Serrano-Vega MJ, Baker JG, Moukhametzianov R, Edwards PC, et al. (2008) Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 454: 486-491.
55. Oliveira L, Paiva ACM, Vriend G, (1993) A common motif in G-protein-coupled seven transmembrane helix receptors. Journal of Computer-Aided Molecular Design 7: 649-658.
56. Gimpl G, Fahrenholz F, (2001) The oxytocin receptor system: structure, function, and regulation. Physiol Rev 81: 629-683.
57. Macrae AD, Premont RT, Jaber M, Peterson AS, Lefkowitz RJ, (1996) Cloning, characterization, and chromosomal localization of rec1.3, a member of the G-protein-coupled receptor family highly expressed in brain. Brain Res Mol Brain Res 42: 245-254.
58. Clark SD, Tran HT, Zeng J, Reinscheid RK, (2010) Importance of extracellular loop one of the neuropeptide S receptor for biogenesis and function. Peptides 31: 130-138.
59. Mouillac B, Chini B, Balestre MN, Elands J, Trumpp-Kallmeyer S, et al. (1995) The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions. J Biol Chem 270: 25771-25777.
60. Conner M, Hawtin SR, Simms J, Wootten D, Lawson Z, et al. (2007) Systematic analysis of the entire second extracellular loop of the V(1a) vasopressin receptor: key residues, conserved throughout a G-protein-coupled receptor family, identified. J Biol Chem 282: 17405-17412.
61. Sanchez D, Ganfornina MD, Gutierrez G, Marin A, (2003) Exon-intron structure and evolution of the Lipocalin gene family. Mol Biol Evol 20: 775-783.
62. Cazzamali G, Hauser F, Kobberup S, Williamson M, Grimmelikhuijzen CJ, (2003) Molecular identification of a Drosophila G protein-coupled receptor specific for crustacean cardioactive peptide. Biochem Biophys Res Commun 303: 146-152.
63. Zingg HH, (1996) Vasopressin and oxytocin receptors. Baillieres Clin Endocrinol Metab 10: 75-96.
64. Oksche A, Rosenthal W, (1998) The molecular basis of nephrogenic diabetes insipidus. J Mol Med (Berl) 76: 326-337.
65. Majewski J, Ott J, (2002) Distribution and characterization of regulatory elements in the human genome. Genome Res 12: 1827-1836.
66. Qiu WG, Schisler N, Stoltzfus A, (2004) The evolutionary gain of spliceosomal introns: sequence and phase preferences. Mol Biol Evol 21: 1252-1263.
67. Sverdlov AV, Rogozin IB, Babenko VN, Koonin EV, (2005) Conservation versus parallel gains in intron evolution. Nucleic Acids Res 33: 1741-1748.
68. Schwarz DA, Barry G, Eliasof SD, Petroski RE, Conlon PJ, et al. (2000) Characterization of gamma-aminobutyric acid receptor GABAB(1e), a GABAB(1) splice variant encoding a truncated receptor. J Biol Chem 275: 32174-32181.
69. Vanetti M, Vogt G, Hollt V, (1993) The two isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) differ in coupling efficiency to adenylate cyclase and in agonist-induced receptor desensitization. FEBS Lett 331: 260-266.
70. Wang L, Oh DY, Bogerd J, Choi HS, Ahn RS, et al. (2001) Inhibitory activity of alternative splice variants of the bullfrog GnRH receptor-3 on wild-type receptor signaling. Endocrinology 142: 4015-4025.
71. Surgand JS, Rodrigo J, Kellenberger E, Rognan D, (2006) A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptors. Proteins 62: 509-538.
72. Gloriam DE, Foord SM, Blaney FE, Garland SL, (2009) Definition of the G protein-coupled receptor transmembrane bundle binding pocket and calculation of receptor similarities for drug design. J Med Chem 52: 4429-4442.
73. Gu X, (2001) Maximum-likelihood approach for gene family evolution under functional divergence. Mol Biol Evol 18: 453-464.
74. Gu X, (2006) A simple statistical method for estimating type-II (cluster-specific) functional divergence of protein sequences. Mol Biol Evol 23 (10): 1937-1945.
75. Bichet DG, Birnbaumer M, Lonergan M, Arthus MF, Rosenthal W, et al. (1994) Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus. Am J Hum Genet 55: 278-286.
76. Chini B, Mouillac B, Ala Y, Balestre MN, Trumpp-Kallmeyer S, et al. (1995) Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor. EMBO J 14: 2176-2182.
77. Postina R, Kojro E, Fahrenholz F, (1996) Separate agonist and peptide antagonist binding sites of the oxytocin receptor defined by their transfer into the V2 vasopressin receptor. J Biol Chem 271: 31593-31601.
78. Cotte N, Balestre MN, Phalipou S, Hibert M, Manning M, et al. (1998) Identification of residues responsible for the selective binding of peptide antagonists and agonists in the V2 vasopressin receptor. J Biol Chem 273: 29462-29468.
79. Ufer E, Postina R, Gorbulev V, Fahrenholz F, (1995) An extracellular residue determines the agonist specificity of V2 vasopressin receptors. FEBS Lett 362: 19-23.
80. Erlenbach I, Wess J, (1998) Molecular basis of V2 vasopressin receptor/Gs coupling selectivity. J Biol Chem 273: 26549-26558.
81. Bokoch MP, Zou Y, Rasmussen SG, Liu CW, Nygaard R, et al. (2010) Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor. Nature 463: 108-112.
82. Schertler GF, (2008) Signal transduction: the rhodopsin story continued. Nature 453: 292-293.
83. Ahuja S, Smith SO, (2009) Multiple switches in G protein-coupled receptor activation. Trends Pharmacol Sci 30: 494-502.
84. Hofmann KP, Scheerer P, Hildebrand PW, Choe HW, Park JH, et al. (2009) A G protein-coupled receptor at work: the rhodopsin model. Trends Biochem Sci 34: 540-552.
85. Scheerer P, Heck M, Goede A, Park JH, Choe HW, et al. (2009) Structural and kinetic modeling of an activating helix switch in the rhodopsin-transducin interface. Proc Natl Acad Sci U S A 106: 10660-10665.